And mTORC2 kinase inhibitor Torin1 and Src kinase inhibitor AZD0530 have been identified to synergistically inhibit the growth of IGF2BP1-expressing cancer cells in vitro and in vivo by disrupting IGF2BP1 phosphorylation [129]. This evidence concerns the gene IGF2BP1 and cancer.